Risperidone
Indication
Acute and chronic psychoses, mania; short-term treatment of persistent aggression in patients with moderate to severe Alzheimer's dementia unreponsive to non-pharmacological interventions and where there is a risk of harm to self or others; short-term treatment of persistent aggression in conduct disorder
MHRA Drug Safety Update - Drug name confusion
Amber level 1
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
LSCMMG is adopting the local decisions made prior to April 2013
Recommendation
LSCMMG Recommendation:
Amber level 1
Reason for decision:
Shared care required
Supporting documents: